Trial Profile
Insulin glarigine or NPH combined with metformin in type 2 diabetes: the LANMET study.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 14 Jun 2011
Price :
$35
*
At a glance
- Drugs Insulin glargine (Primary) ; Insulin suspension isophane
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms LANMET
- 05 Nov 2010 New trial record.